patents.google.com

AU2019268061A1 - Placental stem cell populations - Google Patents

  • ️Thu Dec 12 2019

AU2019268061A1 - Placental stem cell populations - Google Patents

Placental stem cell populations Download PDF

Info

Publication number
AU2019268061A1
AU2019268061A1 AU2019268061A AU2019268061A AU2019268061A1 AU 2019268061 A1 AU2019268061 A1 AU 2019268061A1 AU 2019268061 A AU2019268061 A AU 2019268061A AU 2019268061 A AU2019268061 A AU 2019268061A AU 2019268061 A1 AU2019268061 A1 AU 2019268061A1 Authority
AU
Australia
Prior art keywords
placental stem
cell populations
stem cell
stem cells
methods
Prior art date
2005-12-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019268061A
Inventor
Sascha Dawn Abramson
James W. Edinger
Herbert Faleck
Robert J. Hariri
Kristen S. Labazzo
Marian Periera
Jia-Lun Wang
Qian Ye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celularity Inc
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2005-12-29
Filing date
2019-11-19
Publication date
2019-12-12
2006-12-28 Priority claimed from PCT/US2006/049491 external-priority patent/WO2007079183A2/en
2019-11-19 Application filed by Celularity Inc filed Critical Celularity Inc
2019-11-19 Priority to AU2019268061A priority Critical patent/AU2019268061A1/en
2019-12-12 Publication of AU2019268061A1 publication Critical patent/AU2019268061A1/en
2021-07-15 Assigned to Celularity, Inc. reassignment Celularity, Inc. Request for Assignment Assignors: ANTHROGENESIS CORPORATION
2022-03-22 Priority to AU2022201955A priority patent/AU2022201955A1/en
Status Abandoned legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Abstract The present invention provides placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. The invention also provides methods of differentiating the placental stem cells. The invention further provides methods of using the placental stem cells in assays and for transplanting.

AU2019268061A 2005-12-29 2019-11-19 Placental stem cell populations Abandoned AU2019268061A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2019268061A AU2019268061A1 (en) 2005-12-29 2019-11-19 Placental stem cell populations
AU2022201955A AU2022201955A1 (en) 2005-12-29 2022-03-22 Placental stem cell populations

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US75496805P 2005-12-29 2005-12-29
US60/754,968 2005-12-29
US84664106P 2006-09-22 2006-09-22
US60/846,641 2006-09-22
PCT/US2006/049491 WO2007079183A2 (en) 2005-12-29 2006-12-28 Placental stem cell populations
AU2006332678A AU2006332678B2 (en) 2005-12-29 2006-12-28 Placental stem cell populations
AU2014201181A AU2014201181B2 (en) 2005-12-29 2014-03-04 Placental stem cell populations
AU2017248523A AU2017248523A1 (en) 2005-12-29 2017-10-19 Placental stem cell populations
AU2019268061A AU2019268061A1 (en) 2005-12-29 2019-11-19 Placental stem cell populations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2017248523A Division AU2017248523A1 (en) 2005-12-29 2017-10-19 Placental stem cell populations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022201955A Division AU2022201955A1 (en) 2005-12-29 2022-03-22 Placental stem cell populations

Publications (1)

Publication Number Publication Date
AU2019268061A1 true AU2019268061A1 (en) 2019-12-12

Family

ID=50344717

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2014201181A Ceased AU2014201181B2 (en) 2005-12-29 2014-03-04 Placental stem cell populations
AU2017248523A Abandoned AU2017248523A1 (en) 2005-12-29 2017-10-19 Placental stem cell populations
AU2019268061A Abandoned AU2019268061A1 (en) 2005-12-29 2019-11-19 Placental stem cell populations
AU2022201955A Abandoned AU2022201955A1 (en) 2005-12-29 2022-03-22 Placental stem cell populations

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2014201181A Ceased AU2014201181B2 (en) 2005-12-29 2014-03-04 Placental stem cell populations
AU2017248523A Abandoned AU2017248523A1 (en) 2005-12-29 2017-10-19 Placental stem cell populations

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2022201955A Abandoned AU2022201955A1 (en) 2005-12-29 2022-03-22 Placental stem cell populations

Country Status (1)

Country Link
AU (4) AU2014201181B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105408472A (en) 2013-03-15 2016-03-16 马卡斯凯尔·托莱夫·拉尔森 Cells, methods and devices for cord blood collection and cell isolation
EP3439674A4 (en) * 2016-04-07 2019-11-27 Dragonfly Foundation For Research & Development Corp Method and system for repairing damaged tissue using nucleated plasma particles (nuc-p2s) and mesodermal stem cells (mesoscs)
WO2018073615A1 (en) 2016-10-21 2018-04-26 Longboat Explorers Ab Methods and compositions for generating hematopoietic cells
WO2018169554A1 (en) * 2017-03-17 2018-09-20 Longboat Explorers Ab Methods, systems, factors, and media for reduction of cellular stress and reactive oxygen species
US10213465B1 (en) 2017-08-10 2019-02-26 Dragonfly Foundation for Research & Development Corp. Method and system for repairing damaged tissue using nucleated plasma particles (Nuc-P2s) and mesodermal stem cells (MesoSCs)
AU2020368845A1 (en) 2019-10-18 2022-05-12 Amniotics Ab Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2316918B1 (en) * 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
EP1482787A4 (en) * 2002-02-13 2006-02-15 Anthrogenesis Corp Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US20040028660A1 (en) * 2002-05-30 2004-02-12 Anthrogenesis Corporation Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes

Also Published As

Publication number Publication date
AU2017248523A1 (en) 2017-11-09
AU2022201955A1 (en) 2022-04-14
AU2014201181A1 (en) 2014-03-27
AU2014201181B2 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
MX2018012512A (en) 2020-11-12 Placental stem cell populations.
AU2019268061A1 (en) 2019-12-12 Placental stem cell populations
GB2446525A (en) 2008-08-13 Stem cell culture medium and method
WO2006070370A3 (en) 2007-03-08 Stem cells culture systems
WO2008060541A3 (en) 2008-08-28 In vitro expansion of postpartum-derived cells using microcarriers
WO2007044418A3 (en) 2009-04-23 Cell culture media, kits and methods of use
WO2006015209A3 (en) 2006-06-08 Differentiation of stem cells
WO2007008758A3 (en) 2007-03-15 Methods for identifying agents and conditions that modulate neurogenesis
MY159971A (en) 2017-02-15 Multipotent/pluripotent cells and methods
WO2007047468A3 (en) 2007-09-13 Immunomodulation using placental stem cells
SG152273A1 (en) 2009-05-29 Pdx1 expressing endoderm
WO2007100845A3 (en) 2008-11-27 Non-embryonic totipotent blastomere-like stem cells and methods therefor
WO2005047524A3 (en) 2005-12-29 Compositions and methods for inducing cell dedifferentiation
MX356756B (en) 2018-06-11 Pluripotent stem cell culture on micro-carriers.
WO2007026353A3 (en) 2009-05-22 Media for culturing stem cells
WO2007016366A3 (en) 2009-04-30 Defined culture conditions of human embryonic stem cells
TW200734462A (en) 2007-09-16 Regulating stem cells
WO2007028079A3 (en) 2009-04-16 Methods of stimulating expansion of hematopoietic stem cells
WO2010042551A3 (en) 2010-07-01 Methods for providing cellular lysates from cell wall-containing samples
UA92157C2 (en) 2010-10-11 Process for production of growth hormone
WO2004031343A3 (en) 2004-06-24 Human foreskin cells suitable for culturing stem cells
GB2424480A (en) 2006-09-27 Prostate stem cell
WO2004113515A3 (en) 2005-04-14 Tissue modeling in embryonic stem (es) cell system
WO2010036373A3 (en) 2010-07-08 Hematopoietic stem cell growth factor
IL173912A0 (en) 2006-07-05 Follicular fluid for prolonged growth and survival of cells for cell therapies

Legal Events

Date Code Title Description
2021-07-15 PC1 Assignment before grant (sect. 113)

Owner name: CELULARITY, INC.

Free format text: FORMER APPLICANT(S): ANTHROGENESIS CORPORATION

2022-04-14 MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted